DRUG · Unmapped registry intervention
Glycosylated Recombinant Human Interleukin-7
Find medicine records ·
Find other trials using this name
Clinical trial
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
NCT01339000
Drugs and interventions used in this trial
6 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
Diphtheria/Tetanus Vaccine
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Polio Vaccine
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Pneumococcal Vaccine
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Hepatitis A Vaccine
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Hepatitis B Vaccine
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedImproving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Colon Cancerverified · MONDO: malignant colon neoplasm
Bladder Cancerunresolved
Interventions
Diphtheria/Tetanus VaccineBIOLOGICAL
Polio VaccineBIOLOGICAL
Pneumococcal VaccineBIOLOGICAL
Hepatitis A VaccineBIOLOGICAL
Hepatitis B VaccineBIOLOGICAL
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01339000 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.